Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by GILEAD SCIENCES, INC.. Director active across 5 companies, notably Arcus Biosciences, Inc.. Aggregated, 10 disclosures have been published. Breakdown: 8 buys · 0 sell. Total volume traded: €358.8m. Activity tracked since 27 June 2023. The latest transaction was filed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.